- FRC 2027: SFG Residential program | accepting application for Tranche-2 Click Here to know more →
- CSAT Classes for Prelims 2027 by Rishi Bhargav sir starts 16 Nov. at 5 PM Click Here to know more →
- Prelims Sprint classes 2027: Starts 2nd Nov. at 4:30 PM | First class open to all. Click Here to know more →
Source– This post on InfexnTM has been created based on the article “Kerala gears up for India’s 1st genomics-based infectious diseases test” published in “Hindustan Times” on 9 February 2024.
Why in the news?
Kerala’s medical landscape is undergoing a great shift with the introduction of ‘InfexnTM’, a revolutionary next-generation sequencing test. This will be India’s first genomics-based infectious disease test.
About InfexnTM- A Revolutionary Next-Generation Sequencing Test
Description-The ‘infexnTM’ is a state-of-the-art targeted next generation sequencing test.
Objective– To detect any bacterial and/or fungal infection along with detection of relevant antimicrobial resistance genes, within 24 hours.
Developed by– IIT-Bombay-based HaystackAnalytics and NIMS Medicity at Neyyattinkara.
Features-1) The test is a kit-cum-software solution and can be performed within a hospital.
2) It is “Made in India, Made for the World” test.
Significance of InfexnTM
1) It can empower the healthcare ecosystem with advanced, definitive diagnostics. This will ensure optimal antibiotic usage.
2) It will enable effective implementation of the national goal of championing antimicrobial leadership.
3) This innovative approach can enhance the accuracy and efficiency of infectious disease detection.
4) This test ensures that clinicians get efficient and accurate diagnosis of infectious diseases. This will lead to targeted therapy and improved patient outcomes.
5) The ‘InfexnTM’ report can be life-saving for patients with suspected infection.
Read more about- Genome sequencing
UPSC Syllabus-Science & technology.
